Mitophagy
Mitophagy(线粒体自噬)
Mitophagy is the selective degradation of mitochondria by autophagy.
Mitochondria are essential organelles that regulate cellular energy homeostasis and cell death. The removal of damaged mitochondria through autophagy, a process called mitophagy, is thus critical for maintaining proper cellular functions. Indeed, mitophagy has been recently proposed to play critical roles in terminal differentiation of red blood cells, paternal mitochondrial degradation, neurodegenerative diseases, and ischemia or drug-induced tissue injury.
Autophagy and mitophagy are important cellular processes that are responsible for breaking down cellular contents, preserving energy and safeguarding against accumulation of damaged and aggregated biomolecules.
Mitophagy 相关产品(83)
- GC15706Aspirin (Acetylsalicylic acid)CAS: 50-78-2纯度: >99.50%
A non-selective, irreversible COX inhibitor
- GC15794Valproic acid sodium salt (Sodium valproate)CAS: 1069-66-5纯度: >98.00%
Valproic acid sodium salt (Sodium valproate)(VPA)是一种具有口服活性的组蛋白脱乙酰酶 (HDAC)抑制剂,IC 50 值为1.5mM,抑制HDAC1的IC 50 值为400μM,同时可诱导HDAC2的降解。
- GC162676-Hydroxydopamine hydrobromideCAS: 636-00-0纯度: >98.00%
6-Hydroxydopamine hydrobromide (6-OHDA) 是儿茶酚胺、多巴胺和去甲肾上腺素的结构类似物,对儿茶酚胺能神经元发挥毒性作用。
- GC17567Doxorubicin (Adriamycin) HClCAS: 25316-40-9纯度: >99.50% / >98.00%
An anthracycline antitumor antibiotic
- GC17580Olaparib (AZD2281, Ku-0059436)CAS: 763113-22-0纯度: >99.50% / >98.00%
Olaparib (AZD2281, Ku-0059436) 是一种有效的选择性 PARP 抑制剂,特异性靶向 PARP1 和 PARP2(IC 50 分别 = 5 nM 和 1 nM)。
- GC17683Brefeldin ACAS: 20350-15-6纯度: >99.50%
Brefeldin A(BFA)是一种真菌大环内酯,能够有效、可逆地抑制内质网和高尔基体之间的蛋白质运输和囊泡形成。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC14882 | Salinomycin | 53003-10-4 | >98.00% | |
A selective cancer stem cell inhibitor | ||||
| GC14968 | Esmolol HCl | 81161-17-3 | >99.00% | |
A β 1 -AR antagonist | ||||
| GC15083 | Celastrol | 34157-83-0 | >99.50% | |
Celastrol是一种蛋白酶体抑制剂,有效且优先的抑制纯化的20S蛋白酶体,IC 50 为2.5 μM。 | ||||
| GC15617 | Etoposide | 33419-42-0 | >99.50% / >99.00% / >98.50% | |
Etoposide(VP-16)是一种非特异性拓扑异构酶II(Topoisomerase II)抑制剂,IC 50 值为59.2 μM。 | ||||
| GC15618 | Melatonin | 73-31-4 | >99.00% / >98.50% | |
An indoleamine neurohormone that entrains circadian rhythms | ||||
| GC15706 | Aspirin (Acetylsalicylic acid) | 50-78-2 | >99.50% | |
A non-selective, irreversible COX inhibitor | ||||
| GC15794 | Valproic acid sodium salt (Sodium valproate) | 1069-66-5 | >98.00% | |
Valproic acid sodium salt (Sodium valproate)(VPA)是一种具有口服活性的组蛋白脱乙酰酶 (HDAC)抑制剂,IC 50 值为1.5mM,抑制HDAC1的IC 50 值为400μM,同时可诱导HDAC2的降解。 | ||||
| GC15904 | PP242 | 1092351-67-1 | >98.50% | |
Potent inhibitor of mTOR kinase in both mTORC1 and mTORC2 | ||||
| GC15951 | URB597 | 546141-08-6 | >99.00% | |
An inhibitor of FAAH | ||||
| GC16105 | Iohexol | 66108-95-0 | >98.00% | |
Iohexol是一种低渗透压非离子型造影剂,为三碘化苯衍生物,分子量为821.1Da。 | ||||
| GC16124 | Ruxolitinib phosphate | 1092939-17-7 | >99.50% | |
A potent and selective JAK1/JAK2 inhibitor | ||||
| GC16267 | 6-Hydroxydopamine hydrobromide | 636-00-0 | >98.00% | |
6-Hydroxydopamine hydrobromide (6-OHDA) 是儿茶酚胺、多巴胺和去甲肾上腺素的结构类似物,对儿茶酚胺能神经元发挥毒性作用。 | ||||
| GC16508 | Salicylic acid | 69-72-7 | >98.00% | |
An Analytical Reference Standard | ||||
| GC16994 | Doxorubicin | 23214-92-8 | >98.00% | |
多柔比星(Doxorubicin,简称DOX),也被称为阿霉素,是一种蒽环类化合物,具有最广泛的活性谱。 | ||||
| GC17234 | ABT-737 | 852808-04-9 | >98.00% | |
ABT-737作为一种BH3模拟药物,是Bcl-2家族的抑制剂,可抑制Bcl2、Bcl-xL和Bcl-w的活性,IC 50 值<1nM。 | ||||
| GC17340 | Carbamazepine | 298-46-4 | >99.50% | |
卡马西平是一种钠通道阻滞剂,是一种抗惊厥药。 | ||||
| GC17390 | Vorinostat (SAHA, MK0683) | 149647-78-9 | >98.00% / >99.00% | |
An HDAC inhibitor | ||||
| GC17443 | Metformin HCl | 1115-70-4 | >98.00% | |
A biguanide with diverse biological activities | ||||
| GC17567 | Doxorubicin (Adriamycin) HCl | 25316-40-9 | >99.50% / >98.00% | |
An anthracycline antitumor antibiotic | ||||
| GC17580 | Olaparib (AZD2281, Ku-0059436) | 763113-22-0 | >99.50% / >98.00% | |
Olaparib (AZD2281, Ku-0059436) 是一种有效的选择性 PARP 抑制剂,特异性靶向 PARP1 和 PARP2(IC 50 分别 = 5 nM 和 1 nM)。 | ||||
| GC17651 | Sunitinib | 557795-19-4 | >99.00% / >98.00% | |
舒尼替尼Sunitinib(SU 11248)是一种具口服活性的多靶点受体酪氨酸激酶抑制剂,对血管内皮生长因子受体(VEGFR2)和血小板衍生生长因子受体(PDGFRβ)的IC 50 分别为80nM和2nM。 | ||||
| GC17683 | Brefeldin A | 20350-15-6 | >99.50% | |
Brefeldin A(BFA)是一种真菌大环内酯,能够有效、可逆地抑制内质网和高尔基体之间的蛋白质运输和囊泡形成。 | ||||
| GC17874 | Matrine | 519-02-8 | >98.00% | |
苦参碱(Matrine)是一种存在于槐属植物中的生物碱,可作为 kappa 阿片受体和μ-受体激动剂。 | ||||
| GC18049 | GSK2578215A | 1285515-21-0 | >99.50% | |
A potent LRRK2 inhibitor | ||||
